Literature DB >> 15792884

Subthreshold rTMS over pre-motor cortex has no effect on tics in patients with Gilles de la Tourette syndrome.

M Orth1, R Kirby, M P Richardson, A H Snijders, J C Rothwell, M R Trimble, M M Robertson, A Münchau.   

Abstract

OBJECTIVE: A previous study showed no effect of 1Hz repetitive transcranial magnetic stimulation (rTMS) on tics in Gilles de la Tourette Syndrome (GTS). We modified the rTMS protocol in order to investigate some of the possible methodological reasons for the negative outcome in that study.
METHODS: In a single blinded placebo-controlled cross-over study in five GTS patients without obsessive compulsive disorder we probed whether longer trains (1800 stimuli) of 1 Hz pre-motor cortex rTMS at 80% of active motor threshold and application to both hemispheres can improve tics in GTS. This was measured with the Yale Global Tic severity rating scale, the MOVES self-rating scale and video analysis.
RESULTS: We found no significant effect of either left pre-motor cortex stimulation alone, or left pre-motor followed by right pre-motor cortex stimulation.
CONCLUSIONS: These results suggest that the rTMS protocol used in this study is not useful for the treatment of tics in GTS. SIGNIFICANCE: rTMS protocols need to be modified substantially in order to explore their potential for the treatment of tics in GTS.

Entities:  

Mesh:

Year:  2004        PMID: 15792884     DOI: 10.1016/j.clinph.2004.10.003

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  15 in total

Review 1.  Neurobiological substrates of Tourette's disorder.

Authors:  James F Leckman; Michael H Bloch; Megan E Smith; Daouia Larabi; Michelle Hampson
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-08       Impact factor: 2.576

2.  Biofeedback of real-time functional magnetic resonance imaging data from the supplementary motor area reduces functional connectivity to subcortical regions.

Authors:  Michelle Hampson; Dustin Scheinost; Maolin Qiu; Jitendra Bhawnani; Cheryl M Lacadie; James F Leckman; R Todd Constable; Xenophon Papademetris
Journal:  Brain Connect       Date:  2011

Review 3.  Transcranial Magnetic Stimulation for the Treatment of Pediatric Neurological Disorders.

Authors:  Laura A Malone; Lisa R Sun
Journal:  Curr Treat Options Neurol       Date:  2019-11-13       Impact factor: 3.598

Review 4.  Transcranial Magnetic Stimulation in the Treatment of Neurological Diseases.

Authors:  Fahad A Somaa; Tom A de Graaf; Alexander T Sack
Journal:  Front Neurol       Date:  2022-05-20       Impact factor: 4.086

Review 5.  The management of tics.

Authors:  David Shprecher; Roger Kurlan
Journal:  Mov Disord       Date:  2009-01-15       Impact factor: 10.338

6.  Randomized Sham Controlled Double-blind Trial of Repetitive Transcranial Magnetic Stimulation for Adults With Severe Tourette Syndrome.

Authors:  Angeli Landeros-Weisenberger; Antonio Mantovani; Maria G Motlagh; Pedro Gomes de Alvarenga; Liliya Katsovich; James F Leckman; Sarah H Lisanby
Journal:  Brain Stimul       Date:  2014-12-03       Impact factor: 8.955

7.  Brain areas coactivating with motor cortex during chronic motor tics and intentional movements.

Authors:  Michelle Hampson; Fuyuze Tokoglu; Robert A King; R Todd Constable; James F Leckman
Journal:  Biol Psychiatry       Date:  2008-12-25       Impact factor: 13.382

Review 8.  Tourette syndrome and comorbid ADHD: causes and consequences.

Authors:  N El Malhany; M Gulisano; R Rizzo; P Curatolo
Journal:  Eur J Pediatr       Date:  2014-09-17       Impact factor: 3.183

Review 9.  Therapeutic Neurostimulation in Obsessive-Compulsive and Related Disorders: A Systematic Review.

Authors:  Nicola Acevedo; Peter Bosanac; Toni Pikoos; Susan Rossell; David Castle
Journal:  Brain Sci       Date:  2021-07-19

10.  Globus Pallidus Interna in Tourette Syndrome: Decreased Local Activity and Disrupted Functional Connectivity.

Authors:  Gong-Jun Ji; Wei Liao; Yang Yu; Huan-Huan Miao; Yi-Xuan Feng; Kai Wang; Jian-Hua Feng; Yu-Feng Zang
Journal:  Front Neuroanat       Date:  2016-10-14       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.